These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32349886)

  • 1. Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge.
    Ifteni P; Dima L; Teodorescu A
    Schizophr Res; 2020 Jun; 220():265-266. PubMed ID: 32349886
    [No Abstract]   [Full Text] [Related]  

  • 2. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of long-acting injectable antipsychotics: a clinical perspective.
    Castillo EG; Stroup TS
    Evid Based Ment Health; 2015 May; 18(2):36-9. PubMed ID: 25854825
    [No Abstract]   [Full Text] [Related]  

  • 4. Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic.
    Nichols J; Gannon JM; Conlogue J; Sarpal D; Montgomery JL; Sherwood R; Fabian T; Ballough JR; Fredrick NM; Chengappa KNR
    Schizophr Res; 2020 Aug; 222():499-500. PubMed ID: 32473934
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?
    Correll CU; Lauriello J
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics.
    Heres S; Lambert M; Vauth R
    Eur Psychiatry; 2014 Nov; 29 Suppl 2():1409-13. PubMed ID: 25455704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Long-Acting Injectable Antipsychotic Management During COVID-19.
    MacLaurin SA; Mulligan C; Van Alphen MU; Freudenreich O
    J Clin Psychiatry; 2021 Jan; 82(1):. PubMed ID: 33434959
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial impact of a pharmacist-managed clinic for long-acting injectable antipsychotics.
    Phan SV; VandenBerg AM
    Am J Health Syst Pharm; 2012 Jun; 69(12):1014-5. PubMed ID: 22644972
    [No Abstract]   [Full Text] [Related]  

  • 10. Delaying time to relapse in schizophrenia. The role of long-acting injectable antipsychotics.
    Muller R
    Manag Care; 2014 Apr; 23(4 Suppl 1):2-3. PubMed ID: 25029779
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
    Agid O; Foussias G; Remington G
    Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.
    Stevens GL; Dawson G; Zummo J
    Early Interv Psychiatry; 2016 Oct; 10(5):365-77. PubMed ID: 26403538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic.
    Grover S; Mishra E; Chakrabarti S; Mehra A; Sahoo S
    Schizophr Res; 2020 Aug; 222():489-490. PubMed ID: 32563610
    [No Abstract]   [Full Text] [Related]  

  • 16. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.
    Haddad PM; Taylor M; Niaz OS
    Br J Psychiatry Suppl; 2009 Nov; 52():S20-8. PubMed ID: 19880913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health psychology and the coronavirus (COVID-19) global pandemic: A call for research.
    Arden MA; Chilcot J
    Br J Health Psychol; 2020 May; 25(2):231-232. PubMed ID: 32227547
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.
    Pilon D; Alcusky M; Xiao Y; Thompson-Leduc P; Lafeuille MH; Lefebvre P; Benson C
    J Med Econ; 2018 Feb; 21(2):135-143. PubMed ID: 28895766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting injectable antipsychotics in early psychosis: a literature review.
    Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P
    Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Preventive Measures against Coronavirus Disease of 2019 in a Plastic Surgery Unit at the Epicenter of the Pandemic in Italy.
    Facchin F; Scarpa C; Vindigni V; Bassetto F
    Plast Reconstr Surg; 2020 Jul; 146(1):112e-113e. PubMed ID: 32590690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.